tiprankstipranks
Advertisement
Advertisement
Q32 Bio Announces $10.5 Million Registered Direct Offering
PremiumCompany AnnouncementsQ32 Bio Announces $10.5 Million Registered Direct Offering
2M ago
Q32 Bio announces $10.5M registered direct offering
Premium
The Fly
Q32 Bio announces $10.5M registered direct offering
2M ago
Q32 Bio Retains Mark Iwicki as Board Chair
Premium
Company Announcements
Q32 Bio Retains Mark Iwicki as Board Chair
4M ago
Q32 Bio sells complement inhibitor ADX-097 to Akebia for $12M upfront
PremiumThe FlyQ32 Bio sells complement inhibitor ADX-097 to Akebia for $12M upfront
5M ago
Q32 Bio sells complement inhibitor ADX-097 to Akebia
Premium
The Fly
Q32 Bio sells complement inhibitor ADX-097 to Akebia
5M ago
Q32 Bio Inc. Faces Financial Challenges Amid Development Efforts
Premium
Company Announcements
Q32 Bio Inc. Faces Financial Challenges Amid Development Efforts
6M ago
Eight option delistings on August 18th
PremiumThe FlyEight option delistings on August 18th
9M ago
Q32 Bio Inc. Advances Alopecia Areata Treatment with Phase 2a Trial of Bempikibart
Premium
Company Announcements
Q32 Bio Inc. Advances Alopecia Areata Treatment with Phase 2a Trial of Bempikibart
9M ago
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts
Premium
Company Announcements
Q32 Bio Inc. Reports Continued Losses Amid Development Efforts
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100